Delta Gold Technologies plc (Aquis: DGQ / OTC: DGQTF / FRA: O2J) has moved its ordinary shares to the Apex segment of the Aquis Growth Market, with trading commencing on 9 November 2026. The Apex segment represents the top tier of the Aquis Growth Market and is reserved for larger, more established growth companies operating under higher standards of governance and transparency. The transfer from the Access segment marks a significant milestone for the quantum materials company, which only completed its initial admission in December 2025. Investors may be watching whether the upgrade enhances institutional visibility and liquidity as the company advances its commercialisation strategy.

Key Points

  • Delta Gold Technologies plc (Aquis: DGQ / OTC: DGQTF / FRA: O2J)
  • The company has transferred its ordinary shares from the Access segment to the Apex segment of the Aquis Growth Market, effective 9 November 2026
  • The company cited expansion of sponsored research at the University of Toronto and Pennsylvania State University, patent filings, and a strengthened financial position as progress since its December 2025 admission
  • Investors should watch for developments in licensing arrangements, strategic partnerships, and further patent applications across the company's academic collaborations

Delta Gold's Transfer from Access to Apex Segment on Aquis Growth Market

Delta Gold Technologies confirmed in its announcement that it has met the eligibility criteria required for the transfer of its ordinary shares from the Access segment to the Apex segment of the Aquis Growth Market, operated by Aquis Exchange. The Apex segment is designed for companies that apply higher standards of corporate governance, transparency, and market engagement, and is intended to support improved liquidity and broader institutional investor interest. The company described the move as an important milestone reflecting substantial progress made since its admission to the Aquis Growth Market in December 2025.

Quantum Materials Portfolio Spanning Sensing, Communications and Computing

Delta Gold Technologies is developing a portfolio of intellectual property focused on the application of nano-scale gold and other advanced materials in quantum information science. The company's three target areas are quantum sensing, quantum communications, and quantum computing. Its research is conducted through sponsored arrangements with The Pennsylvania State University and the University of Toronto, which the company considers a competitive advantage. The company has secured rights to intellectual property arising from these programmes, including patent applications filed by both academic institutions, and stated it continues to support additional research and patent development across its collaborations.

Progress Since December 2025 Admission Underpins Apex Qualification

Chief Executive Officer R. Michael Jones noted in the announcement that progress since the company's December 2025 admission included the expansion of sponsored research programmes at the University of Toronto and Pennsylvania State University, the filing of patent applications, and what the company described as a strengthening of its financial position. The company did not disclose specific financial metrics in the announcement. Jones stated that Apex status is expected to enhance the company's visibility to institutional and international investors and demonstrate its commitment to high standards of corporate governance and orderly markets.

Commercialisation Strategy Relies on Licensing and Strategic Partnerships

Delta Gold's stated business strategy is to develop, protect, and commercialise novel quantum materials technologies through patent protection, licensing arrangements, and strategic partnerships. The company has also indicated the potential development of devices across its three focus areas. As an early-stage intellectual property business, the company's commercial prospects remain tied to the successful progression of academic research into patentable and licensable technologies. Investors may be watching how the higher-profile Apex listing supports the company's ability to attract institutional capital to fund ongoing research and commercialisation activities.